Company · LIMN (NASDAQ - All Markets)
Liminatus Pharma, Inc.
Biological Products, (No Diagnostic Substances)
Key figures
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Institutional holders
- 13 at 30 Jun 2026 (15 the quarter before)
- SEC number
- 1971387
Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 1 Oct 2026
Rounds and raises
18 Jun 2026
Form D: $2M sold of $2M offered, Pharmaceuticals SEC
Source: SEC EDGAR Form D and the linked articles. All raises this week
Questions and answers
- Where is Liminatus Pharma, Inc. listed?
- Liminatus Pharma, Inc. trades as LIMN on NASDAQ - All Markets. Tamarly shows no share prices.
- How many institutions hold Liminatus Pharma, Inc.?
- 13 institutional holders reported it on SEC Form 13F for the period ended 30 Jun 2026, against 15 the quarter before.
With a free account
A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.